These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31540393)

  • 1. Deletion of Gb3 Synthase in Mice Resulted in the Attenuation of Bone Formation via Decrease in Osteoblasts.
    Hamamura K; Hamajima K; Yo S; Mishima Y; Furukawa K; Uchikawa M; Kondo Y; Mori H; Kondo H; Tanaka K; Miyazawa K; Goto S; Togari A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of GD3 Synthase in Mice Resulting in the Attenuation of Bone Loss with Aging.
    Yo S; Hamamura K; Mishima Y; Hamajima K; Mori H; Furukawa K; Kondo H; Tanaka K; Sato T; Miyazawa K; Goto S; Togari A
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globo-series Gb4 activates ERK and promotes the proliferation of osteoblasts.
    Kato H; Nagao M; Furukawa K; Mishima Y; Ichikawa S; Sato T; Miyazawa K; Hamamura K
    J Oral Biosci; 2024 Mar; 66(1):41-48. PubMed ID: 37939880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of Bone Formation through a Decrease in Osteoblasts in Mutant Mice Lacking the GM2/GD2 Synthase Gene.
    Sasaki E; Hamamura K; Mishima Y; Furukawa K; Nagao M; Kato H; Hamajima K; Sato T; Miyazawa K; Goto S; Togari A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
    Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
    Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins.
    Okuda T; Tokuda N; Numata S; Ito M; Ohta M; Kawamura K; Wiels J; Urano T; Tajima O; Furukawa K; Furukawa K
    J Biol Chem; 2006 Apr; 281(15):10230-5. PubMed ID: 16476743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Multifarious Functions of Leukotrienes in Bone Metabolism.
    Amadeu de Oliveira F; Tokuhara CK; Veeriah V; Domezi JP; Santesso MR; Cestari TM; Ventura TMO; Matos AA; Dionísio T; Ferreira MR; Ortiz RC; Duarte MAH; Buzalaf MAR; Ponce JB; Sorgi CA; Faccioli LH; Buzalaf CP; de Oliveira RC
    J Bone Miner Res; 2023 Aug; 38(8):1135-1153. PubMed ID: 37314430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair.
    Georgy SR; Pagel CN; Ghasem-Zadeh A; Zebaze RM; Pike RN; Sims NA; Mackie EJ
    Bone; 2012 Mar; 50(3):704-12. PubMed ID: 22173052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.
    Furlan F; Galbiati C; Jorgensen NR; Jensen JE; Mrak E; Rubinacci A; Talotta F; Verde P; Blasi F
    J Bone Miner Res; 2007 Sep; 22(9):1387-96. PubMed ID: 17539736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
    Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
    Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products.
    Fujii Y; Numata S; Nakamura Y; Honda T; Furukawa K; Urano T; Wiels J; Uchikawa M; Ozaki N; Matsuo S; Sugiura Y; Furukawa K
    Glycobiology; 2005 Dec; 15(12):1257-67. PubMed ID: 16079416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globotriaosyl ceramide and globoside as major glycolipid components of fibroblasts in scirrhous gastric carcinoma tissues.
    Sawada R; Hotta H; Chung YS; Sowa M; Tai T; Yano I
    Jpn J Cancer Res; 1998 Feb; 89(2):167-76. PubMed ID: 9548444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal globotriaosylceramide facilitates tubular albumin absorption and its inhibition protects against acute kidney injury.
    Morace I; Pilz R; Federico G; Jennemann R; Krunic D; Nordström V; von Gerichten J; Marsching C; Schießl IM; Müthing J; Wunder C; Johannes L; Sandhoff R; Gröne HJ
    Kidney Int; 2019 Aug; 96(2):327-341. PubMed ID: 31101366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
    Gilbert LC; Chen H; Lu X; Nanes MS
    Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA4 represses RANKL in osteoblasts via multiple long-range enhancers to regulate osteoclast differentiation.
    Khalid AB; Slayden AV; Kumpati J; Perry CD; Berryhill SB; Crawford JA; Fatima I; Morselli M; Pellegrini M; Miranda-Carboni GA; Krum SA
    Bone; 2018 Nov; 116():78-86. PubMed ID: 30031905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice.
    Okamoto M; Murai J; Imai Y; Ikegami D; Kamiya N; Kato S; Mishina Y; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2011 Oct; 26(10):2511-22. PubMed ID: 21786321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 as a novel regulator of osteoblast-osteoclast interaction and bone homeostasis.
    Simon D; Derer A; Andes FT; Lezuo P; Bozec A; Schett G; Herrmann M; Harre U
    Bone; 2017 Dec; 105():35-41. PubMed ID: 28822790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel, promoter-based, target-specific assay identifies 2-deoxy-D-glucose as an inhibitor of globotriaosylceramide biosynthesis.
    Okuda T; Furukawa K; Nakayama K
    FEBS J; 2009 Sep; 276(18):5191-202. PubMed ID: 19674101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.